Cerebrospinal fluid oxidative stress during chemotherapy of acute lymphoblastic leukemia in children

Pediatric Hematology and Oncology

Volumn 27, Issue 4, 2010, Pages 306-313

  Protas, Piotr T ^a   Muszynska Roslan, Katarzyna ^a   Holownia, Adam ^a   Krawczuk Rybak, Maryna ^a   Braszko, Jan J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

8 isoprostane; Acute lymphoblastic leukemia; Chemotherapy; Neurotoxicity

Indexed keywords

8 ISOPROSTANE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; LACTATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; MALE; NEUROTOXICITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; DINOPROST; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 77951779885     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880011003639960     Document Type: Article

References (23)

1. Rivera GK, Pinkel D, Simone JV, et al. Treatment of acute lymphoblastic leukemia: 30 years of experience at St. Jude Children's Research Hospital. N Engl J Med. 1993; 329: 1289-1295.
2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008; 371: 1030-1043.
3. Hallbook H, Gustafsson G, Smedmyr B, et al. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer. 2006; 107: 1551-1561.
4. Kingma A, van Dommelen RI, Mooyaart EL, et al. Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr. 2001; 139: 413-420.
5. Iuvone L, Mariotti P, Colosimo C, et al. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer. 2002; 95: 2562-2570.
6. Glover DA, Byrne J, Mills JL, et al. Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children's Cancer Group. J Clin Oncol. 2003; 21: 4395-4401.
7. Hill JM, Kornblith AB, Jones D, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer. 1998; 82: 208-218.
8. Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev. 2006; 12: 174-183.
9. Møller P, Risom L, Lundby C, et al. Hypoxia and oxidation levels of DNA and lipids in humans and animal experimental models. IUBMB Life. 2008; 60: 707-723.
10. Valko M, Rhodes CJ, Moncola J, et al. Free radicals, met al.s and antioxidants in oxidative stressinduced cancer. Chem Biol Interact. 2006; 160: 1-40.
11. Masutani H. Oxidative stress response and signaling in hematological malignancies and HIV infection. Int J Hematol. 2000; 71: 25-32.
12. Manoharan S, Kalanjiappan K, Kayalvizhi M. Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell Mol Biol Lett. 2004; 9: 699-707.
13. Battisti V, Maders LD, Bagatini MD, et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem. 2008; 41: 511-518.
14. Mazor D, Abucoider A, Meyerstein N, et al. Antioxidant status in pediatric acute lymphocytic leukemia (ALL) and solid tumors: the impact of oxidative stress. Pediatr Blood Cancer. 2008; 51: 613-615.
15. Surtees R, Clelland J, Heales S. Cerebrospinal fluid concentrations of nitrate plus nitrite during the treatment of acute lymphoblastic leukaemia in childhood. Leuk Res. 1998; 22: 751-754.
16. Al-Gayyar MM, Eissa LA, Rabie AM, El-Gayar AM. Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients. J Pharm Pharmacol. 2007; 59: 409-417.
17. Quinn CT, Griener JC, Bottiglieri T, et al. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol. 1997; 15: 2800-2806.
18. Rajamani R, Muthuvel A, Senthilvelan M, et al. Oxidative stress induced by methotrexate alone and in the presence of methanol in discrete regions of the rodent brain, retina and optic nerve. Toxicol Lett. 2006; 165: 265-273.
19. Vezmar S, Schüsseler P, Becker A, et al. Methotrexate-associated alterations of the folate and methyltransfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity. Pediatr Blood Cancer. 2009; 52: 26-32.
20. Zhou Y, Hileman EO, Plunkett W, et al. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood. 2003; 101: 4098-4104.
21. Van Gool SW, De Meyer G, Van de Voorde A, et al. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia. Neurotoxicology. 2004; 25: 471-480.
22. Osterlundh G, Kjellmer I, Lannering B, et al. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children. Pediatr Blood Cancer. 2008; 50: 793-798.
23. Cole PD, Beckwith KA, Vijayanathan V, et al. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia. Pediatr Neurol. 2009; 40: 34-41.